Global Pharmaceutical Partnering Terms and Agreements 2017-2022


Global Pharmaceutical Partnering Terms and Agreements 2017 to 2022 report provides a detailed understanding and analysis of how and why companies enter Pharmaceutical partnering deals. 

Publication date
September 2022
Number of pages
Product type
Research report
Available formats
PDF document
Report edition

Global Pharmaceutical Partnering Terms and Agreements 2017 to 2022 report provides a detailed understanding and analysis of how and why companies enter Pharmaceutical partnering deals. 


This report provides details of the latest Pharmaceutical agreements announced in the life sciences since 2017.


The report takes the reader through a comprehensive review Pharmaceutical deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Pharmaceutical partnering deals.


The report presents financial deal term values for Pharmaceutical deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.


The middle section of the report explores the leading dealmakers in the Pharmaceutical partnering field; both the leading deal values and most active Pharmaceutical dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.


One of the key highlights of the report is that over 8,000 online deal records of actual Pharmaceutical deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.


In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.


The initial chapters of this report provide an orientation of Pharmaceutical dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Pharmaceutical dealmaking since 2017, including details of headline, upfront, milestone and royalty terms.


Chapter 3 provides a review of the leading Pharmaceutical deals since 2017. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.


Chapter 4 provides a comprehensive listing of the top 25 most active companies in Pharmaceutical dealmaking with a brief summary followed by a comprehensive listing of Pharmaceutical deals announded by that company, as well as contract documents, where available.


Chapter 5 provides a comprehensive and detailed review of Pharmaceutical partnering deals signed and announced since Jan 2017, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.


Chapter 6 provides a comprehensive and detailed review of Pharmaceutical partnering deals signed and announced since Jan 2017. The chapter is organized by specific technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


A comprehensive series of appendices is provided organized by Pharmaceutical partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


The report also includes numerous tables and figures that illustrate the trends and activities in Pharmaceutical partnering and dealmaking since 2017.


In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Pharmaceutical technologies and products.


Key benefits


Global Pharmaceutical Partnering Terms and Agreements 2017 to 2022 provides the reader with the following key benefits:


  • In-depth understanding of Pharmaceutical deal trends since 2017
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Pharmaceutical contracts entered into by leading biopharma companies
  • Identify most active Pharmaceutical dealmakers since 2017
  • Insight into terms included in a Pharmaceutical partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Report scope


Global Pharmaceutical Partnering Terms and Agreements 2017 to 2022 is intended to provide the reader with an in-depth understanding and access to Pharmaceutical trends and structure of deals entered into by leading companies worldwide.


Pharmaceutical Partnering Terms and Agreements includes:


  • Trends in Pharmaceutical dealmaking in the biopharma industry since 2017
  • Access to headline, upfront, milestone and royalty data
  • Access to Pharmaceutical contract documents
  • Leading Pharmaceutical deals by value since 2017
  • Most active Pharmaceutical dealmakers since 2017


In Global Pharmaceutical Partnering Terms and Agreements 2017 to 2022, the available deals are listed by:


  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type


Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


The Global Pharmaceutical Partnering Terms and Agreements 2017 to 2022 report provides comprehensive access to available deals and contract documents for over 8,000 Pharmaceutical deals.


Analyzing actual contract agreements allows assessment of the following:


  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Pharmaceutical Partnering Terms and Agreements 2017 to 2022 provides the reader with the following key benefits:


  • In-depth understanding of Pharmaceutical deal trends since 2017
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Pharmaceutical contracts entered into by leading biopharma companies
  • Identify most active Pharmaceutical dealmakers since 2017
  • Insight into terms included in a Pharmaceutical partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary


Chapter 1 – Introduction


Chapter 2 – Trends in Pharmaceutical dealmaking


2.1. Introduction

2.2. Pharmaceutical partnering over the years

2.3. Most active Pharmaceutical dealmakers

2.4. Pharmaceutical partnering by deal type

2.5. Pharmaceutical partnering by therapy area

2.6. Pharmaceutical partnering by technology type

2.7. Deal terms for Pharmaceutical partnering

2.7.1 Pharmaceutical partnering headline values

2.7.2 Pharmaceutical deal upfront payments

2.7.3 Pharmaceutical deal milestone payments

2.7.4 Pharmaceutical royalty rates


Chapter 3 – Leading Pharmaceutical deals


3.1. Introduction

3.2. Top Pharmaceutical deals by value


Chapter 4 – Most active Pharmaceutical dealmakers


4.1. Introduction

4.2. Most active Pharmaceutical dealmakers

4.3. Most active Pharmaceutical partnering company profiles


Chapter 5 – Pharmaceutical contracts dealmaking directory


5.1. Introduction

5.2. Pharmaceutical contracts dealmaking directory


Chapter 6 – Pharmaceutical dealmaking by technology type




Appendix 1 – Pharmaceutical deals by company A-Z

Appendix 2 – Pharmaceutical deals by stage of development

Appendix 3 – Pharmaceutical deals by deal type

Appendix 4 – Pharmaceutical deals by therapy area

Appendix 5 – Deal type definitions

Appendix 6 – Further reading


About Wildwood Ventures


Current Partnering

Current Agreements

Recent report titles from Current Partnering


Table of figures


Figure 1: Pharmaceutical partnering since 2017
Figure 2: Active Pharmaceutical dealmaking activity– 2017 to 2022
Figure 3: Pharmaceutical partnering by deal type since 2017
Figure 4: Pharmaceutical partnering by disease type since 2017
Figure 5: Pharmaceutical partnering by technology type since 2017
Figure 6: Pharmaceutical deals with a headline value
Figure 7: Pharmaceutical deals with an upfront value
Figure 8: Pharmaceutical deals with a milestone value
Figure 9: Pharmaceutical deals with a royalty rate value
Figure 10: Top Pharmaceutical deals by value since 2017
Figure 11: Most active Pharmaceutical dealmakers 2017 to 2022

Pricing options


  • $3,995: single-user
  • $5,745: multi-user
  • $10,995: single site license
  • $17,995: global site license


A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.


Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1QBit, 2cureX, 3B Pharmaceuticals, 3D Medicines, 3D Systems, 3P Biopharmaceuticals, 3SBio, 4D Molecular Therapeutics, 4D Pharma, 4G Clinical, 7 Hills Pharma, 9 Meters Biopharma, 22nd Century, 23andMe, 48North Cannabis, 111, 1717 Life Science Ventures, A*STAR Singapore Immunology Network, A2 Biotherapeutics, A2A Pharmaceuticals, Aarhus University, Aarhus University Hospital, Aavis Pharmaceuticals, Abacus International, Abarca, Abattis Bioceuticals, Abba Import Export, Abba Medix, AB Biosciences, Abbisko Therapeutics, Abbott Laboratories, Abbott Vascular Devices, Abbvie, Abby Grace Foundation, Abcam, AbCellera, ABEC, Ab E Discovery, Abeona Therapeutics, AbFero Pharmaceuticals, Abide Therapeutics, AB InBev, Abingworth Management, Abionic, ABL Bio, Ablexis, Ablynx, Abpro, Abramson Cancer Center, AbSci, Absorption Systems, Abuse Deterrent Pharmaceuticals, ABX, Abzena, Acacia Pharma, ACADIA Pharmaceuticals, Acasti Pharma, AC Bioscience, Accelerate Brain Cancer Cure, Acceleron Pharma, Accent Therapeutics, Accenture, Accord Healthcare, Accumulus Synergy, Acelity, Acell, Acella Pharmaceuticals, Acelrx Pharmaceuticals, Acentrus Specialty, Acepodia, Acerta Pharma, Acer Therapeutics, Acerus, Achaogen, Ache, Achieve Life Science, AC Immune, Acino Pharma, Aclaris Therapeutics, Aclipse Therapeutics, Acnos Pharma, Acorda Therapeutics, Acres Cannabis, Acrotech Biopharma, Actavis (acquired by Watson), Actelion, ACT Genomics, Actimed Therapeutics, Actinium Pharmaceuticals, ActiveSite, Activhealth, Acturum Life, Acuity Pharmaceuticals, Acura Pharmaceuticals, AcuraStem, Acurx Pharmaceuticals, Adacyte Therapeutics, Adamas Pharmaceuticals, Adamis Pharmaceuticals, Adapsyn Bioscience, Adaptimmune, Adaptive Biotechnologies, Adaptive Health, Adapt Pharma, Adare Pharma Solutions, ADC Therapeutics, Addex Therapeutics, Addgene, AdhereTech, Adhezion Biomedical, Adial Pharmaceuticals, ADIENNE Pharma & Biotech, Adimab, Adjuvance Technologies, Adlai Nortye, ADL Bionatur Solutions, ADMA Biologics, adMare BioInnovations, Adocia, AdoRx Therapeutics, Adrestia, ADT Pharmaceuticals, Adult Brain Tumor Consortium, Aduro BioTech, Advanced Accelerator Applications, Advanced BioScience Laboratories, Advanced Extraction Systems, Advanced Medical Solutions, Advanced Neural Dynamics, Advanced Proteome Therapeutics, Advanced Regenerative Manufacturing Institute, Advance Pharmaceutical, Advanz Pharma, Advaxis, Advent International, Advocate Health Care, Adynxx, Aegerion Pharmaceutical, Aegis Therapeutics, Aeglea BioTherapeutics, Aeon Bioscience, Aequus Pharmaceuticals, Aerami Therapeutics, Aerie Pharmaceuticals, Aerogen, Aeromics, Aerpio Pharmaceuticals, AEssenseGrows, Aesthetic Management Partners, AEterna Zentaris, Aetion, Aevi Genomic Medicine, Aevum Life Science, Afaxys Pharmaceuticals, AffaMed Therapeutics, Affigen, Affimed Therapeutics, Affinia Therapeutics, Affinivax, AffyXell Therapeutics, AFT Pharmaceuticals, AGC Asahi Glass, AGC Biologics, Age Labs, AgeneBio, Agenus Bio, Aghraas-Cigalah, Agios Pharmaceuticals, Aglon, AgMedica Bioscience, AgonOx, AgriCann Solutions, Agrium, Agro-Greens Natural Products, AiCuris, AIDS Foundation Houston, AIDS Foundation of Chicago, AIkido Pharma, AIM ImmunoTech, AIMM Therapeutics, Aimmune Therapeutics, AiPing Pharmaceutical, Aither Ingredient, AIT Laboratories, AIT Therapeutics, AiVita Biomedical, Ajinomoto, AJU Pharma, Akaal Pharma, Akcea Therapeutics, Akebia Therapeutics, Aker BioMarine, Akero Therapeutics, Akili Interactive Labs, Akkadeas Pharma, AKL Research and Development, Akston Biosciences, Akula Trading 2 Pty, Akums Drugs and Pharmaceuticals, Alamo Pharma Services, Albany Molecular Research, Alberta Health Services, Albert Einstein College of Medicine, Albireo, Albumedix, Alcami, Alcanna, Alcyone Lifesciences, Alder Biopharmaceuticals, Aldeyra Therapeutics, Aleafia Health, Alector, Alexion Pharmaceuticals, Alexza Pharmaceuticals, Alfasigma, Algae-C, Algae Dynamics, Algenex, Algernon Pharmaceuticals, Al Hafez Trading Establishment, Aligos Therapeutics, Alimera Sciences, AliveGen, Alivio Therapeutics, ALK-Abello, Alkahest, Alkermes, Allecra Therapeutics, Allegis Holdings, Allegro Ophthalmics, Allele Biotechnology and Pharmaceuticals, Allergan, Allergan Aesthetics, Alliance For Clinical Trials In Oncology, Alliance Pharma, Alliancepharma Technologies, AllianceRx Walgreens Prime, Allianz Bioinnovation, Allied Corp, Allm, Allogene Overland Biopharm, Allogene Therapeutics, Allscripts, AllStripes, Almac Diagnostics, Almac Discovery, Almac Group, Almirall, Alnylam Pharmaceuticals, Alopexx, Alpha Cognition, Alphageneron Pharmaceuticals, Alphagen Laboratories, Alphamab Biopharmaceuticals, Alpha Tau Medical, Alpine Hemp Group, Alpine Immune Sciences, ALRISE Biosystems, ALS Association, Altavant Sciences, Alteogen, Alterity Therapeutics, Alternative Solutions, Alternavida, AltMed Florida, Altopa, Altum Pharmaceuticals, Altus Formulation, Alveo Technologies, Alvit LCS Pharma, Alvogen, Alvotech, ALX Oncology, Alytas Therapeutics, AlzeCure Pharma, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Alzheon, AlzProtect, Amag Pharmaceuticals, Amal Therapeutics, Amarantus BioSciences, Amarex Clinical Research, Amarin, Amazon Web Services, Ambiopharm, Ambrosia Nutraceuticals, Ambrosus, Ambrx, Ambys Medicines, AM Chemicals, A Menarini Diagnostics, American Association for Cancer Research, American BriVision, American Cancer Society, American College of Cardiology, American National Multiple Sclerosis Society, American Regent, American Society for Parenteral and Enteral Nutrition, American Society of Hematology, Amerigen Pharmaceuticals, AmerisourceBergen, Amgen, Amgros, Amneal Pharmaceuticals, Amolyt Pharma, Amomed Pharma, AMO Pharma, Amorsa Therapeutics, Amoy Diagnostics, AMP German Cannabis, Amphastar Pharmaceuticals, Amphilix, Amplity Health, Amplyx Pharmaceuticals, AMRA Medical, Amring Pharmaceuticals, Amryt, AMSL, Amunix, Amydis Diagnostics, Amygdala Neurosciences, Amyndas Pharmaceuticals, Amyris, AN2 Therapeutics, AnaBios, Anaeropharma, Anahit, Analytics 4 Life, AnaMar, ANANDA Scientific, Anatara Lifesciences, Anavex Life Sciences, Anchiano Therapeutics, Andor Pharmaceuticals, Anergis, Angelini Pharma, AnGes MG, Angiochem, Angion Biomedica, AnHeart Therapeutics, Anika Therapeutics, Anima Biotech, Animal Clinical Investigation, ANI Pharmaceuticals, Anivive Lifesciences, Anixa Biosciences, Anji Pharma, Anokion, ANP Technologies, Ansun Biopharma, Antares Pharma, Antengene, Anteris Bio, Anthem, Anthos Therapeutics, Antibe Therapeutics, AntibioTx, Antigen Express, Antikor Biopharma, Antoxerene, AntriaBio, Apceth, APC Therapeutics, Apeiron Biologics, Apellis Pharmaceuticals, Apex Global Brands, Apexian Pharmaceuticals, Apexigen, Aphex BioCleanse Systems, Aphria, Apipharm Veletrgovina, APL, Aplagon, Apobiologix, ApolloBio, Apollo Green, Apollomics, Apollo Therapeutics, ApoPharma, Apotex, Appello Pharmaceuticals, AppianRx, Appili Therapeutics, Apple, Applied Biology, Applied BioMath, Applied Botanics, Applied DNA Sciences, Applied Pharmaceutical Innovation, APR Applied Pharma Research, Aprecia Pharmaceuticals, Apricity Health, Apsen Farmacutica, APS Healthcare, AptaBio Therapeutics, Aptahem, Aptarion biotech, Aptar Pharma, Aptevo Therapeutics, Aptinyx, Aptorum Group, Aptose Biosciences, APT Therapeutics, Aptuit, Aqilion, Aquestive Therapeutics, Aquila BioMedical, Aquinnah Pharmaceuticals, Aquinox Pharmaceuticals, Aradigm, Aragen Bioscience, Aralez Pharmaceuticals, Aratana Therapeutics, Aravive Biologics, Arbele, Arbor Biotechnologies, Arbutus, ARCA Biopharma, Arcadia Biosciences, Arcadia Consumer Healthcare, Arcellx, Arch Biopartners, Archer Daniels Midland Company, ArcherDX, ARC Therapeutics, Arctic Vision, Arctoris, Arcturus Therapeutics, Arcus Biosciences, Arcutis Biotherapeutics, Ardelyx, Arecor, Arena Pharmaceuticals, Argentia Gold, Argentum Pharmaceuticals, argenx, Aridis Pharmaceuticals, Aries Pharmaceuticals, Arisan Therapeutics, Aris Global, Aristea Therapeutics, Arix Bioscience, Arjuna Naturals, Ark Biosciences, Armas Pharmaceuticals, Armata Pharmaceuticals, Armis Biopharma, Arno Therapeutics (inactive since 2017), Aro Biotherapeutics, Arpeggio Biosciences, ArQule, Arrakis Therapeutics, Array Biopharma, Arrevus, Arrien Pharmaceuticals, Arrowhead Pharmaceuticals, Arrow Pharmaceuticals, Arrys Therapeutics, ArsenalBio, ARS Pharmaceuticals, Arteaus Therapeutics, ArtemiLife, Artios Pharma, Artisan Bio, Artiva Biotherapeutics, Artizan Biosciences, ARTMS Product, Aruvant Sciences, Arvelle Therapeutics, Arvinas, Asahi Kasei, Ascendia Pharmaceuticals, Ascendis Pharma, Ascend Therapeutics, Ascensia Diabetes Care, Ascentage Pharma, Ascletis, Ashion Analytics, Ashvattha Therapeutics, Asieris MediTech, ASKA Pharmaceuticals, AskAt, Asklepios Biopharmaceutical, Aslan Pharma, ASM International, Aspargo Laboratories, Aspen Holding, Aspen Pharmacare Canada, Assembly Biosciences, Assertio Therapeutics, Assistance Publique-Hôpitaux de Paris, Assuta Medical Centers, Astellas Pharma, Astex Pharmaceuticals, AstraZeneca, AstronauTx, Asymchem Laboratories, ATAI Life Sciences, Atalanta Therapeutics, Atara Biotherapeutics, AtCor Medical, Atea Pharmaceuticals, aTen Therapeutics, ATG Allied Technologies, Athenex, Athersys, Atlab Pharma, Atlantic Healthcare, Atnahs Pharma, Atomwise, Atrapos Therapeutics, Atreca, ATUM, aTyr Pharma, Aucta Pharmaceuticals, Audentes Therapeutics, Auditus, Augmenta, AUM Biosciences, Aura Biosciences, Auransa, Aurena Laboratories, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Auris Medical, Aurobindo Pharma, Auron Therapeutics, Aurora Cannabis, AusHealth, Australian Research Council, Authentic Brands Group, Autifony Therapeutics, Autolus, Autotelic BIO, Auxly Cannabis Group, Avacta, Avactis Biosciences, Avadel Pharmaceuticals, Avalere Health, Avalon GloboCare, Avanos Medical, AvantGen, Avara Pharmaceutical Services, Avaria Health & Beauty, AV Cannabis, AVEO Oncology, Avicanna, Avid Bioservices, Avidity Biosciences, Avillion, Avion Pharmaceuticals, Avista Pharma Solutions, Avitide, AvKARE, Avomeen, Avondale Pharmaceuticals, Axcelon Dermacare, AXIM Biotechnologies, Axis Therapeutics, Axovant Gene Therapies, Axsome Therapeutics, Ayala Pharmaceuticals, Ayogo Health, AyoxxA Biosystems, Aytu BioScience, Azitra, AzurRx BioPharma, Bach Biosciences, Bachem, Back-A-Line, Bactevo, Baergic Bio, Baheal Pharmaceutical, Bain Capital, Baker Brothers Investments, Banner Health, Banyan Biomarkers, Barbara Ann Karmanos Cancer Institute, Barer Institute, BASF, Basilea Pharmaceutica, BAS Research, Batavia Biosciences, Battelle, Bausch & Lomb, Bausch Health Companies, Bavarian Nordic, Baxalta, Baxter International, Bayer, Bayer Animal Health, Bayer Healthcare, Baylor College, Baylor College of Medicine, BayMedica, Bazelet, Bazis NN, B Braun, BCD Bioscience, BDD Pharma, Beacon Discovery, Beam Therapeutics, Beckley Canopy Therapeutics, Beckley Foundation, Becton Dickinson, BehaVR, BeiGene, Beijing Genomics Institute (BGI), Beijing InnoCare Pharma, Beijing Keyuan Xinhai Pharma, Beijing SL Pharma, Beijing Tide Pharmaceutical, Beijing Zhongyuan, Beleave, Bellicum Pharmaceuticals, Bellus Health, Ben-Gurion University, Bendalis, Bened Biomedical, BenevolentAI, Benitec Biopharma, Benuvia Therapeutics, BE Pharmaceuticals, Berg, BerGenBio, Berkeley Lights, Berkshire Sterile Manufacturing, Berlin Chemie, Berry Genomics, Besins Healthcare, Best Choice, Best Medical International, Betaliq, Beta Pharma, Beta Therapeutics, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Betta Pharmaceuticals, Better Choice Products, BetterLife Pharma, BevCanna, Bexson Biomedical, Beyond Air, BGN Technologies, Bhang, Bharat Biotech, BHB Therapeutics, Bial, Bicycle Therapeutics, Bigfoot Biomedical, Bill and Melinda Gates Foundation, Binex, Bintai Kinden, Bio-Techne, Bio-Thera Solutions, Bio-Tissue, BioAge Labs, BioArctic Neuroscience, BioAscent Discovery, biOasis Technologies, BioAtla, BioAxone Therapeutic, BioBlast Pharma, BioCad Holding, BioCanRx, BioCardia, Biocartis, BioCelerate, Biocept, Biocodex, Biocon, BIOCORP, BioCorRx, BioCryst Pharmaceuticals, BioCurate, BioDelivery Sciences, Biodelta Nutraceuticals, Biodextris, Bioeq IP, Biofortis, Bioforum, Biofourmis, Biogen, BioGenetics, Bioharmony Therapeutics, Biohaven Pharmaceutical Holding, Biohealth Innovation, Biohit, BioInvent, Biokin Pharmaceutical, BioLabs, BioLab Sciences, BioLamina, BioLife Solutions, BioLite Japan, Biological E, Biologics, BioMarin Pharmaceutical, BioMatrix Specialty Pharmacy, Biomed Elements, Biomedical Advanced Research and Development Authority, BIOMEDX Group, BioMed X Innovation Center, Biomerica, bioMerieux, Biometrix, Biomica, Biomillenia, Biomm, bioMONTR Labs, BioMotiv, Biomunex Pharmaceuticals, BiomX, Bioncotech Therapeutics, Biond Biologics, BiondVax, Bionical, Bioniz Therapeutics, Bionpharma, BioNTech, Bionure, Bio Palette, Biopharma-Middle East and Africa, Biopharmaceuticals Australia, BioPharma Plasma, Biophore Pharmaceuticals, Bio Products Laboratory, Bioprojet, BioQ Pharma, BioRAE, BioreclamationIVT, BioReference Laboratories, Bioscience, Bioscience Enterprises, Bioscience Pharma Partners, BioSciencesCorp, BioSense Global, BioSerenity, BioSight, BioSig Technologies, Biosolution, Biosortia Pharmaceuticals, BioSurfaces, BioSyent Pharma, BioSymetrics, Biosynth, Biosynthetic Technologies, Biotechnology Industry Research Assistance Council, Biotest, Biotest Pharmaceuticals, Biothera Pharmaceuticals, Biotop, Biotoscana Farma, Biotropical, BioVectra, Bioventus, Bioverativ, BioVersys, BioXcel, Birdie Biopharmaceuticals, Biscayne Neurotherapeutics, BL&H, Blackford, Blacksmith Medicines, Blackstone, Blackstone Medical, BlackThorn Therapeutics, Blake Insomnia Therapeutics, Blanver, Bliss Biopharmaceutical, BLLRDR, Bloom Medicinals, Bloom Science, BLP Management, Blueberries Medical, Bluebird Bio, Bluelink Pharmaceuticals, Blue Mesa Health, Blueprint Medicines, Blue Water Vaccines, BMG Pharmaceuticals, BMV Medica, BodyLogicMD, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bold Therapeutics, Bone Therapeutics, Bonify, Bonne Santé Group, Bonus BioGroup, Bophelo Bioscience & Wellness, Boragen, Bora Pharmaceuticals, Boryung Pharmaceutical, Boston Biomedical, Boston Pharmaceuticals, Boston Scientific, Boston Therapeutics, Boston Topicals, Boston University School of Medicine, Boulos and Cooper Pharmaceuticals, BPL Medical Technologies, Bracco Imaging, Brammer Bio, Breath of Life International, Breath Therapeutics, Breckenbridge Pharmaceutical, Breckenridge Pharmaceuticals, BrickBio, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, Bridgewest Group, Brigham and Women's Hospital, Bright Future Pharmaceutical Lab, BrightInsight, Brii Biosciences, Brill Pharma, Brink Biologics, Briotech, Bristol-Myers Squibb, Bristol-Myers Squibb Pakistan, British Columbia Liquor Distribution Branch, BRNT, Broad Institute, Brown University, Bryn Pharma, BryoLogyx, BTG, Buck Institute for Age Research, Bugworks, Bukwang Pharmaceuticals, Burke Therapeutics, Burleigh Heads Cannabis, Burning Rock, Butantan Institute, BVF Partners, C-Bridge Capital, C-Tri, C4 Therapeutics, C4X Discovery, Cadent, Cadila Pharmaceuticals, Caelum Biosciences, Caladrius Biosciences, Calcimedica, Caldera Pharmaceuticals, CALECIM Cosmeceuticals, Calico, Califia Pharma, California Institute for Biomedical Research, California Institute for Regenerative Medicine, Caligor, Calithera Biosciences, Caliva, Calixar, Calliditas Therapeutics, Calvert Labs, Calvert Research, Calypso Biotech, Camargo Pharmaceutical Services, Cambrex, Cambridge Commodities, Cambrooke Therapeutics, Camena Bioscience, Camino Pharma, CAMP4 Therapeutics, Camurus, Can-Fite BioPharma, Canada House Wellness Group, CANbridge Life Sciences, Cancer Genetics, Cancer Prevention and Research Institute of Texas, Cancer Prevention Pharmaceuticals, Cancer Research Institute, Cancer Research UK, Cancer Science Institute of Singapore, Cancer Targeted Technology, CanCure, Candel Therapeutics, Cannabics Pharmaceuticals, Cannabis Biocare, Cannabis Global, Cannabis Medical Solutions, Cannabis Science, Cannabis Suisse, Cannabis Therapeutics, CannaBR Exports, CannAcubed, CannaCure, CannaHoldCo, CannaKids, Cannamedical Pharma, CannAmerica Brands, CannaRoyalty, CannaSoul Analytics, Cannassure Therapeutics, Cannatrek Medical, Canndeo, Cannidex Brands, Cannika, CanniMed Therapeutics, Cannomed Medical Cannabis Industries, CannRx Technology, Canntab Therapeutics, CannTrust, CannTx Life Sciences, Cannus Partners, Cannvalate, Canopy Growth, Canopy Health Innovations, CanProbe, Cantabio Pharmaceuticals, Cantabria Pharma, Cantargia, Cantek, Cantex Pharmaceuticals, Canymed, Cap Alter Pharma, Capcium, Capna Intellectual, Capricor Therapeutics, Captor Therapeutics, Cara Care, Cara Therapeutics, CARB-X, Cardinal Health, Cardiogen Sciences, Cardiome Pharma, Cardiovascular Solutions of Central Mississippi, Cardiovascular Systems, Cardurion Pharmaceuticals, Care Access Research, Carestream Health, Caret Pharma, Caretta Therapeutics, Carisma Therapeutics, Carmel Pharma, Carmine Therapeutics, Carmot Therapeutics, Carna BioSciences, Carnot BioSciences, Carrick Therapeutics, Casa Schmidt, Cascade Chemistry, Cascade Pure, Cascadian Therapeutics, CASI Pharmaceuticals, Casma Therapeutics, Cassava Sciences, Cassiopea, Castle Creek Pharmaceuticals, Catabasis Pharmaceuticals, Catalent, Catalyst Pharmaceutical Partners, Catalyst Pharmaceuticals, Cato Research, CB2 Insights, CB2 Therapeutics, CBDerma Technology, CBD Export Global, CBDistribution, cbdMD, CBD Vida, CB Therapeutics, CBT Pharmaceuticals, CC Pharma, CCT Research, CDR-Life, Cedars-Sinai Medical Center, Cedilla Therapeutics, Cediprof, Ceek Women's Health, Celator, Celdara Medical, Celgene, CellAct, Cellares, Cellecta, Cellectar Biosciences, Cellectis, Cellenkos, Cellerant Therapeutics, Celling Biosciences, CELLINK, Cellix Bio, CellSight Technologies, Cellthera Pharma, Celltrion, Cellular Biomedicine, Cellular Logistics, Celmatix, Celsee, Celsius Therapeutics, Celularity, Celyad, Censa Pharmaceuticals, Centers for Disease Control and Prevention, Centogene, Centre for Cellular and Molecular Platforms, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Drug Research and Development (CDRD), Centre for Human Drug Research, Centre Hospitalier Universitaire Vaudois (CHUV), Centre International de Developpment Pharmaceutique, Centrexion, Centric Health Resources, Centro de Investigación Biomédica en Red de Salud Mental, Centurion, Cephagenix, Cepheid, CereCare, Cerecor, CereHealth, Cerenis Therapeutics, Cerevance, Cerevel Therapeutics, CerSci Therapeutics, Certara, Cerulean Pharma, Cerveau Technologies, Ceva Sante Animale, Cevec Pharmaceuticals, CG Oncology, cGreen, ChadTough Foundation, Champions Oncology, Changchun BCHT Biotechnology, Changchun High & New Technology Industries, Changshan Pharm, Chansu Vascular Technologies, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Charles River Laboratories, CHDI Foundation, Checkmate Pharmaceuticals, CheckPoint Immunology, Checkpoint Therapeutics, Cheetah Medical, Cheil Pharm, Chelexa Biosciences, Chembio Diagnostics, ChemDiv, Chemesis, Chemical Abstracts Service (CAS), Chemi Pharmaceutical, ChemoCentryx, ChemWerth, Cheplapharm Arzneimittel, Chi-Med, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital of Philadelphia, Chimerix, China Grand Pharma, China Grand Pharmaceutical, China Medical System, China National Biotech Group (CNBG), China Oncology Focus, China Pharma Holdings, China Resources Guokang Pharmaceuticals, China Resources Sanjiu Medical and Pharmaceutical, Chinese Academy of Sciences, Chinese Future Industry Investment Fund, Chinmax Medical Systems, Chinook Therapeutics, Chong Kun Dang, Chongqing Jingdong Pharmaceutical, Choom, CHO Plus, Chr Hansen, Christiana Care Health System, ChromaDex, Chrysalis BioTherapeutics, Chugai Pharmaceutical, Cidara Therapeutics, Cilag AG, Cincinnati Children’s Hospital Medical Center, CinCor Pharma, Cinda Bio-Pharmaceutical, Cingulate Therapeutics (CTx), Cipher Pharmaceuticals, Cipla, Cipla Medpro, Circassia, Circuit Clinical, Ciron Drugs & Pharmaceuticals, Citius Pharmaceuticals, Citrine Medicine, City of Hope, CIVCO Radiotherapy, Civetta Therapeutics, CiVi Biopharma, Civica Rx, CJ Corp, Clarion Medical Technologies, Clarity Pharmaceuticals, ClearPath, Clearside Biomedical, Clearwater Canngrow, Cleave Therapeutics, Clene Nanomedicine, Cleveland Clinic, Cleveland Diabetes Care, Cleveland University Hospitals, Click Therapeutics, ClinCapture, Clinical Trial and Consulting Services, Clinigen, Clinton Health Access Initiative, Clintrex Research, Clinuvel Pharmaceuticals, CloudNine, Cloud Pharmaceuticals, Clover Biopharmaceuticals, Clover Therapeutics, Clovis Oncology, CMAB Biopharma, CMC Biologics, CMIC, CMS Medical, CNS Pharmaceuticals, Co-Formulate, Coalition for Epidemic Preparedness Innovations, Cobra Biologics, Cochlear, Cocoon Biotech, Cocrystal Pharma, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, Cogia Biotech, Cognition Kit, Cognition Therapeutics, CogState, Coherus Biosciences, Cold Genesys, Collaborative Trajectory Analysis Project, Collagen Solutions LLC, Collegium Pharmaceuticals, Collplant, Color, Colorado Center for Personalized Medicine, Colorado Hemp Project, Columbia Care, Columbia Technology Ventures, Columbia University, Comercializadora BioRenal, Commense, CommonSense, Commonwealth of Pennsylvania, Community Shield, Compact Imaging, Compassionate Cultivation, Complement Pharma, Complete Phytochemical Solutions, Compugen, Conatus Pharmaceuticals, Conavi Medical, Concept Life Sciences, Concerto HealthAI, Concert Pharmaceuticals, Concord Biosciences, Concordia Pharmaceuticals, Confo Therapeutics, Consilient Health, Constance Therapeutics, Contamac, Context Therapeutics, CONTINUUS Pharmaceuticals, ContraVir Pharmaceuticals, ConvaTec, Convelo Therapeutics, ConverGene, Convergent Bioscience, Cook Biotech, Cooper-Vemedia, Cooper Surgical, Copernicus Therapeutics, Corbus Pharmaceuticals, CoreRx Pharma, Corino Therapeutics, Corix Bioscience, Cornell University, Corning, Coronado Biosciences, Corporation for Biological Research, Correvio Pharma, Corsair Pharma, Corvidia Therapeutics, Corvus Pharmaceuticals, Cosmed Group, Cosmo Pharmaceuticals, COTA, COUR Pharmaceutical, Courtagen Life Sciences, Covar Pharmaceuticals, COVAX, COVAXX, Covistat, Cranford Pharmaceuticals, Creapharm, Crescendo Biologics, Crescita Therapeutics, Cresset, Crestone Pharma, Crinetics, CRISPR Therapeutics, CROMA Pharma, Cromos Pharma, Cronos Group, Crown Bioscience, Crown Laboratories, CR Pharma, CRT Pioneer Fund, CryoPort, CrystalGenomics, CSIRO, CSL, CSL Behring, CSPC Pharmaceutical Group, CStone Pharmaceuticals, CTC Group, CTI BioPharma, CUBRC, Cue Biopharma, Cullinan Oncology, Cumberland Emerging Technologies, Cumberland Pharmaceuticals, Cumulus Oncology, Curadev Pharma, Curadigm, Cura Partners, Curative Biotechnology, Cure Duchenne, Cure Genetics, CURE Pharmaceutical, Cures Within Reach, Curetis, CureVac, Curium, Curon Biopharmaceutical, Currax Pharmaceuticals, Custopharm, Cutanea Life Sciences, Cutia Therapeutics, CVC Capital Partners, CVS Caremark, CV Sciences, CVS Pharmacy, Cybin, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cycle Pharmaceuticals, Cyclerion Therapeutics, Cyclica, Cyclolab, Cyclotek, Cyclo Therapeutics, CymaBay Therapeutics, Cyndea Pharma, Cyntar Ventures, Cypralis, Cyrano Therapeutics, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Cystic Fibrosis Trust, Cytiva, Cytocom, Cytodyn, Cytokinetics, CytomX Therapeutics, Cytoo, CytoReason, CytoSorbents, CYTOVIA Therapeutics, Cyxone, D. Western Therapeutics Institute, Daavlin, Dabur, Daewoong Pharmaceutical, Daiichi Sankyo, Dainippon Sumitomo Pharma, Dalhousie University, Dalton Pharma Services, Dana-Farber Cancer Institute, DanCann Pharma, Dance Biopharm, DannCan Pharma, Dare Bioscience, DarwinHealth, DAS Therapeutics, Datavant, David H. Koch Institute for Integrative Cancer Research, DayTwo, DCPrime, DEARhealth, Debiopharm, Dechra Pharmaceuticals, Decibel Therapeutics, Deciphera Pharmaceuticals, DEEP 6 AI, Deerfield Management, Defence Science and Technology Laboratory, Defense Threat Reduction Agency, Deinove, Delcath Systems, DelMar Pharmaceuticals, Delpor, DelSiTech, Delta, Delta 9 Cannabis, DeMelle OncoPharma, DemeRx, Denali Therapeutics, Denka, Denka-KEW Genomics, Denovo Biopharma, Densmore Pharmaceutical, Dent Neurologic Institute, Department of Defence, Department of Defense, Department of Energy, Department of Health and Human Services, Department of Veterans Affairs, DepoMed, DePuy, DermaConcepts, Dermala, Dermavant Sciences, Dermelix Biotherapeutics, Dermira, Desma HC, Destiny Pharma, DeuteRx, Devonian Health Group, Dewpoint Therapeutics, Dexcel Pharma, DexCom, Diabeloop, Diaceutics, DiaMedica, Diamond Light Source, Diamond Therapeutics, Diannei Biotechnology, Dianomi Therapeutics, Diaprost, DiCE Molecules, Dicerna Pharmaceuticals, DIEM Labs, Diffusion Pharmaceuticals, DigiPath Solutions, Digital Therapeutics Alliance, DILIsym Services, Dimerix Biosciences, DiNAQOR, DionyMed Brands, Diplomat, Disc Medicine, Discuva, Distributed Bio, Distribution Solutions Phils, Diurnal, Divergence Neuro Technologies, Diverse Biotech, Diversigen, Dizal Pharmaceutical, DKSH, DKT, dMed Biopharmaceuticals, DMS Health Technologies, DNAtrix, DNX Biopharmaceuticals,, Dogma Therapeutics, DolCas-Tenshi Bioceuticals, DolCas Biotech, Domainex, Domain Therapeutics, Dompe Farmaceutici, Dona Blanca, Dong-A Pharmaceutical, Dong-A ST, DongKoo Bio & Pharma, Door Pharmaceuticals, Doppel Farma, Dorizoe Lifesciences, Dosecann, Dova Pharmaceuticals, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Biosciences, Dragonfly Therapeutics, Dragon Master Foundation, Draper Laboratories, Drawbridge Health, Dr Bragi Company, Dreamy, Drexel University, Dr Kerklaan Therapeutics, Dr Pfleger, Drugs for Neglected Diseases Initiative, DSG, DSM, DSM Sinochem Pharmaceuticals, DuChemBio, Duchenne UK, Duchesnay, Duke-NUS Graduate Medical School Singapore, Duke Clinical Research Institute (DCRI), Duke University, Durbin Group, Durect, Dutch Passion Seed Company, Dyadic International, DyNAbind, Dynacure, DynamiCARE, Dynamic Blending, Dynavax Technologies, Dyno Therapeutics, DynPort Vaccine Company, Dystrophic Epidermolysis Bullosa Research Association of America, E-Scape Bio, E-Therapeutics, Eagle Pharmaceuticals, EA Pharma, Easton Pharmaceuticals, Eaststone, Ebn Sina Medical, Ecobrands, Ecole Polytechnique Federale de Lausanne, EDAP TMS, Eddingpharm, Edelris, Eden BioCell, Edge Pharma, EdiGene, Edison Nation, Editas Medicine, Educational and Scientific, eFFECTOR Therapeutics, EffRx, Egalet, Egle Therapeutics, EicOsis, Eidos Therapeutics, Eiger BioPharmaceuticals, EIP Eczacibasi Ilac Pazarlama, EirGenix, EirGen Pharma, Eisai, Eisai Inc, Elanco, Elanix Biotechnologies, Elasmogen, Elcelyx Therapeutics, ELC Group, Eldan, Elektrofi, Elev8 Brands, Elevar Therapeutics, Elevation Oncology, Elevian, Elexopharm, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Elite Pharmaceuticals, Ellipses Pharma, Ellume, Elpiscience, ElsaLys Biotech, Elsevier, Elucidata, Elysium Health, Embark Biotech, EMD Serono, Emendo Biotherapeutics, Emerald Health Therapeutics, Emerald Organic Growth, Emerge Health, Emergence Therapeutics, Emergent BioSolutions, Emergent Group, Emerson Resources, Emery Pharma, EMMAC Life Sciences, Emmaus Life Sciences, Emmaus Medical, Emory University, Empatica, Empirico, Empower Clinics, EMS, Emulate, Enable Injections, Enamine, Enara Bio, Encoded Therapeutics, Encore Dermatology, Encore Life, Encore Medical, Endocanna Health, EndoCeutics, Endocyte, Endo International, EndoLogic, Endomag, Endotherm, Endo Ventures, endpoint Clinical, Enesi Pharma, Engage Therapeutics, Engitix, Enigma Biomedical, Enleofen Bio, Ennaid Therapeutics, Enochian Biosciences, Entasis Therapeutics, Entegra Laboratories, Entera Health, Enteris Biopharma, Enterome Bioscience, Enterprise Therapeutics, Entheogenix Biosciences, Entheon Biomedical, Entos Pharmaceuticals, Entourage Phytolab, Entrinsic Health Solutions, Envisia Therapeutics, EnWave, ENYO Pharma, Enzymatica, Enzymotec, Enzyre, Enzyvant Science, EpicentRx, Epicore Biosystems, Epidemiologic Solutions, EpiDestiny, Epigen Biosciences, EPI Health, EpimAb Biotherapeutics, EpiPharma, Epirium Bio, EpiThany, Epitomee Medical, Epivax, Epizyme, EPS International, EQRx, Equilab International, Equillium, Equinox Science, Er-Kim, Erasmus University Medical Center, Ergomed, ERP Biomarker Qualification Consortium, ERS Genomics, Erytech, Escient Pharmaceuticals, EspeRare Foundation, Esperion Therapeutics, Espero Biopharma, ESSA Pharma, Essex Bio-Technology, EtectRx, Eternygen, eTheRNA immunotherapies, Ethicann Pharmaceuticals, Ethicon Endo-Surgery, Ethismos Research, Ethos Veterinary Health, Ethypharm, ETH Zurich, Eticann S.A.S. Zomac, Eton Pharmaceuticals, Eufloria Medical, Eu Hwa, Eureka Eurostars, Eurofarma, Eurofins Discovery, Eurofins Scientific, European Biomedical Research Institute of Salerno, European Commission, European Molecular Biology Laboratory, European Organization for Research and Treatment of Cancer, European Union, European Union Regional Development Fund, European Vaccine Initiative, EUSA Pharma, Euthymics Bioscience, Eutilex, Eve & Co, Evecxia, Everads Therapy, Everest Medicines, EverInsight Therapeutics, Evero Health, Eversana, Evestra, Evgen Pharma, Evidation Health, Evofem, Evoke Pharma, Evolve BioSystems, Evommune, Evonik Industries, EVOQ Therapeutics, Evotec, Evox Therapeutics, Evozyne, Ewopharma, Exact Sciences, Exactus, Exagen Diagnostics, Excelera Network, Excelra, Excivion, Exela Pharma Sciences, Exelixis, Exeltis, Exicure, EXMceuticals, Exonate, Exosome Diagnostics, Expansion Therapeutics, Experic, Expesicor, Express Scripts, ExScientia, Eybna Technologies, EyeCare Services Partners, EyeCRO, Eyegate Pharmaceuticals, Eyenovia, EyePoint Pharmaceuticals, Eyevance, F-Star, Fabre Kramer Pharmaceuticals, Fabric Genomics, Factoria Bogar, Faes Farma, Fagron, FairJourney Biologics, FameWave, Fannin, Fapon Biopharma, Farmacias Magistrales, Farmalider, FarmaMondo Group, Fate Therapeutics, Fatro, Fauna Bio, FCM Global, Fedecore, Fedora Pharmaceuticals, Feel Better, Feinstein Institute for Medical Research, Feldan Therapeutics, FerGene, Fermentalg, Ferndale Pharma Group, Ferozsons Laboratories, Ferrer International, Ferring Pharmaceuticals, Fibriant, Fibrocell Science, FightMND, Fillmed, Finch Therapeutics, Fine Foods & Pharmaceuticals N.T.M., Finorga, Firebrand Therapeutics, Firsthand Technology, First Horizon Pharmaceuticals, First Wave Bio, Fission Labs LATAM, FitBit, Five Prime Therapeutics, FKD Therapies, Flamma, Flatiron Health, Flexion Therapeutics, Florence, Florida Hospital, Florida Pharmaceutical Products, Flowerkist, Flower One, Fluence Bioengineering, Fluum, FLX Bio, Flynn Pharma, Foamix Pharmaceuticals, Focus Laboratories, Foghorn Therapeutics, Folia Biotech, Fondazione San Raffaele, Fondazione Telethon, Food and Drug Administration (FDA), Forbius, ForDoz Pharma, Forendo Pharma, Foresee Pharmaceuticals, Forge Therapeutics, Formac Pharmaceuticals, FORMA Therapeutics, Forte Biotechnology, Fortelinea Software Systems, Fortify Therapeutics, Fortive, Fortress Biotech, Forty Seven, Forward Pharma, Fosun Kite Biotechnology, Fosun Pharmaceutical, Fougera Pharmaceuticals, Foundation Consumer Healthcare, Foundation for Innovative New Diagnostics, Foundation for International Urogynecological Assistance, Foundation Medicine, Four 20 Pharma, Four Points Innovation, FoxBio, Fox Chase Cancer Center, Fox Chase Chemical Diversity Center, Fraunhofer Institute for Molecular Ecology (IME), Frazier Healthcare Ventures, Fred Hutchinson Cancer Research Center, Frenova Renal Research, Frequency Therapeutics, Fresenius Kabi Pharmaceuticals, Fresenius Medical Care, Frontida BioPharm, Frontier Biotech, Frontier Medicines, Frontier Scientific Services, Front Range Biosciences, Fruit Slabs, FSD Pharma, Fujifilm, Fujifilm Kyowa Kirin Biologics, Fuji Pharma, Fujirebio Diagnostics, Fujitsu Laboratories, Fulcrum Therapeutics, Fulgent Pharma, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Fusion Genomics, Fusion Pharmaceuticals, Futura Medical, Fuzionaire Diagnostics, Fuzionaire Radioisotope Technologies, G&W Laboratories, G1 Therapeutics, G3 Pharmaceuticals, G3 Therapeutics, GABA Therapeutics, Gabriel Science, GACI Global, Gadeta, Gad Medical Equipment, Gaia, Gain Therapeutics, Galapagos, Galderma

For a full list contact us at

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!